Abstract
Background: Dysbiosis is related to changes in the composition and behaviour of intestinal microbiota, which may contribute to an age-related decline in metabolic and immune system functioning (immune-senescence).
Objective: The microbiota-targeted dietary and probiotic interventions have been shown to favorably affect the host health by an enhancement of antioxidant activity, improving immune homeostasis, suppression of chronic inflammation, regulation of metabolism and prevention of insulin resistance.
Results: In our study, the use of specific probiotics strains improved the serum concentration of glycemic markers, thereby promoting better overall health.
Conclusion: Probiotics may help correct defects in the gut microbial environment improving metabolic parameters, such as blood sugar levels, glycosylated hemoglobin and a decrease in body weight.
Keywords: Probiotics, translational medicine, Vitamin D, cholecalciferol, Banaba leaf extracts, Lagerstroemia speciosa.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Evaluation of a Nutraceutical Product with Probiotics, Vitamin D, Plus Banaba Leaf Extracts (Lagerstroemia speciosa) in Glycemic Control
Volume: 21 Issue: 7
Author(s): Luca Signorini, Andrea Ballini*, Roberto Arrigoni*, Francesco De Leonardis, Rajiv Saini, Stefania Cantore, Danila De Vito, Maria Franca Coscia, Gianna Dipalma, Luigi Santacroce and Francesco Inchingolo
Affiliation:
- Department of Biosciences, Biotechnologies and Biopharmaceutics, Campus Universitario “Ernesto Quagliariello”, University of Bari “Aldo Moro”, Bari,Italy
- CNR Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), Bari,Italy
Keywords: Probiotics, translational medicine, Vitamin D, cholecalciferol, Banaba leaf extracts, Lagerstroemia speciosa.
Abstract:
Background: Dysbiosis is related to changes in the composition and behaviour of intestinal microbiota, which may contribute to an age-related decline in metabolic and immune system functioning (immune-senescence).
Objective: The microbiota-targeted dietary and probiotic interventions have been shown to favorably affect the host health by an enhancement of antioxidant activity, improving immune homeostasis, suppression of chronic inflammation, regulation of metabolism and prevention of insulin resistance.
Results: In our study, the use of specific probiotics strains improved the serum concentration of glycemic markers, thereby promoting better overall health.
Conclusion: Probiotics may help correct defects in the gut microbial environment improving metabolic parameters, such as blood sugar levels, glycosylated hemoglobin and a decrease in body weight.
Export Options
About this article
Cite this article as:
Signorini Luca , Ballini Andrea*, Arrigoni Roberto *, De Leonardis Francesco , Saini Rajiv, Cantore Stefania , De Vito Danila , Coscia Franca Maria , Dipalma Gianna , Santacroce Luigi and Inchingolo Francesco , Evaluation of a Nutraceutical Product with Probiotics, Vitamin D, Plus Banaba Leaf Extracts (Lagerstroemia speciosa) in Glycemic Control, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (7) . https://dx.doi.org/10.2174/1871530320666201109115415
DOI https://dx.doi.org/10.2174/1871530320666201109115415 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Galanin/GALP Receptors and CNS Homeostatic Processes
CNS & Neurological Disorders - Drug Targets Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Meet the Editorial Board:
Current Drug Targets Anti-Proliferative Effects of Novel Glyco-Lipid-Arsenicals (III) on MCF-7 Human Breast Cancer Cells
Medicinal Chemistry Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism
Current Drug Targets Topical Delivery of Antioxidants
Current Drug Delivery Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Endocannabinoid Blockade and the Cardiovascular System
Current Drug Therapy Atrial Remodeling and Novel Pharmacological Strategies for Antiarrhythmic Therapy in Atrial Fibrillation
Current Medicinal Chemistry Hypertension in Older Patients
Current Hypertension Reviews Selar (<i>Selar crumenophthalmus</i>) Fish Protein Hydrolysate Has Antidiabetic Properties Possibly through GLP-1
Current Nutrition & Food Science How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design Vitamin D and Sepsis: From Associations to Causal Connections
Inflammation & Allergy - Drug Targets (Discontinued) The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Adipokines, Metabolism and the Immune Response in the Regulation of Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Antisense DNA and RNA: Potential Therapeutics for Viral Infection
Anti-Infective Agents in Medicinal Chemistry Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence
Protein & Peptide Letters Editorial [Hot Topic: Current Hypertension Reviews: Hot Topics Hypertension and Diabetes: An Emphasis on the RAS (Guest Editors: Karin A.M. Jandeleit-Dahm and Terri J. Allen)]
Current Hypertension Reviews The State of the Art on the Use of Oral Fluid as Alternative Specimen in Forensic Toxicology
Current Pharmaceutical Analysis